









Markets
/
Stocks
/
nasdaq-lmat
/

LeMaitre Vascular Inc

LMAT

111.576USD

+3.716+3.45%

Market hours （ET）Quotes delayed by 15 min

1.70BMarket Cap

43.75P/E TTM



LeMaitre Vascular Inc

111.576

+3.716+3.45%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of LeMaitre Vascular Inc

Currency: USD Updated: 2026-03-24

Key Insights

LeMaitre Vascular Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 4 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 110.50.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

LeMaitre Vascular Inc's Score

Industry at a Glance

Industry Ranking

4 / 209

Overall Ranking

48 / 4547

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

LeMaitre Vascular Inc Highlights

StrengthsRisks

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 29.00% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 249.60M.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 32.65%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 32.65%.

Fairly Valued

The company’s latest PE is 43.13, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 21.55M shares, decreasing 4.86% quarter-over-quarter.

Held by Joel Greenblatt

Star Investor Joel Greenblatt holds 16.03K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.42.

Analyst Rating

Based on 9 analysts

Buy

Current Rating

110.500

Target Price

+3.94%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-24

The current financial score of LeMaitre Vascular Inc is 8.84, ranking 16 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 64.45M, representing a year-over-year increase of 15.68%, while its net profit experienced a year-over-year increase of 39.32%.

Score

Industry at a Glance

Previous score

8.84

Change



Financials

8.22

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.41

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.29

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.87

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.40

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

LeMaitre Vascular Inc's Company Valuation

Currency: USD Updated: 2026-03-24

The current valuation score of LeMaitre Vascular Inc is 4.49, ranking 192 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 43.13, which is 68.80% below the recent high of 72.80 and 21.26% above the recent low of 33.96.

Score

Industry at a Glance

Previous score

4.49

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 4/209

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-24

The current earnings forecast score of LeMaitre Vascular Inc is 8.00, ranking 65 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 108.00, with a high of 120.00 and a low of 90.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 9 analysts

Buy

Current Rating

110.500

Target Price

+3.94%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

LeMaitre Vascular Inc

LMAT

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-24

The current price momentum score of LeMaitre Vascular Inc is 9.34, ranking 5 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 120.77 and the support level at 93.78, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.32

Change

0.02

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-1.390

Neutral

RSI(14)

62.185

Neutral

STOCH(KDJ)(9,3,3)

53.198

Neutral

ATR(14)

3.729

High Vlolatility

CCI(14)

18.362

Neutral

Williams %R

34.430

Buy

TRIX(12,20)

0.706

Sell

StochRSI(14)

52.830

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

108.802

Buy

MA10

108.993

Buy

MA20

107.882

Buy

MA50

95.415

Buy

MA100

90.234

Buy

MA200

89.095

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-24

The current institutional shareholding score of LeMaitre Vascular Inc is 10.00, ranking 1 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 94.99%, representing a quarter-over-quarter increase of 0.74%. The largest institutional shareholder is The Vanguard, holding a total of 1.62M shares, representing 7.10% of shares outstanding, with 1.72% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

2.87M

-1.42%

The Vanguard Group, Inc.

Star Investors

1.59M

-0.18%

LeMaitre (George W)

1.70M

+0.97%

Conestoga Capital Advisors, LLC

1.57M

-1.80%

First Trust Advisors L.P.

828.95K

+35.44%

Copeland Capital Management, LLC

940.33K

-5.02%

Geneva Capital Management LLC

912.25K

-0.33%

State Street Investment Management (US)

800.86K

-1.18%

Congress Asset Management Company, LLP

692.27K

+2.71%

Geode Capital Management, L.L.C.

527.17K

+1.42%

Risk Assessment

Currency: USD Updated: 2026-03-24

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of LeMaitre Vascular Inc is 8.70, ranking 19 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.67. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. LeMaitre Vascular Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.